Vaccination Against Cancer and Chronic Diseases
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The aim of the Section “Vaccination Against Cancer and Chronic Diseases” is to highlight recent advances in vaccine-based approaches for the prevention and treatment of cancer and other chronic diseases. This Section will provide a platform for novel insights into immunological mechanisms, translational applications, and the development of next-generation therapeutic vaccines.
Scope
We welcome articles examining the design, development, and evaluation of vaccines targeting cancer and chronic diseases, including autoimmune disorders, metabolic syndromes, and chronic infections. Topics may include nanoparticle and virus-like particle-based technologies, mRNA and conventional vaccines, neoantigen discovery, tumor microenvironment-targeted immunotherapies, and personalized cancer vaccines. We invite submissions addressing preclinical and clinical studies, and encourage translational research that bridges experimental findings with human applications. We will consider original research articles, brief reports, reviews, and others relevant article types.
Keywords
- cancer vaccines
- chronic disease immunotherapy
- neoantigen discovery
- mRNA vaccines
- dendritic cell-based vaccines
- tumor immunology
- personalized immunotherapy
- preclinical models
- immune checkpoint inhibitors
- cancer prevention
- clinical trials
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Dendritic Cells (DCs) and Cancer Immunotherapy: 2nd Edition (Deadline: 31 July 2026)
- Vaccination for Patients with Hematologic Diseases (Deadline: 31 August 2026)
- Cancer Vaccines and Immunotherapies (Deadline: 30 September 2026)
- Cancer Vaccines and Immunotherapy: Latest Advances, Limitations and Prospects (Deadline: 30 November 2026)
- Epidemiology, Immunology, and Therapeutic Vaccines of Enteric Pathogens (Deadline: 30 November 2026)
- The Era of Vaccines: Advancing Tumor Immunology and Immunotherapy (Deadline: 30 November 2026)
- Developing Recombinant Vaccines and Immunotherapy Strategies for Emerging Viral Diseases (Deadline: 31 December 2026)
- Cancer Vaccines: Current Advances, Clinical Applications, and Future Directions (Deadline: 31 December 2026)
- Nanotechnology for Cancer Vaccines (Deadline: 31 December 2026)
- Cancer Vaccines: 4th Edition (Deadline: 31 January 2027)
- Advances in Cancer Immunotherapy and Vaccines Research: 2nd Edition (Deadline: 28 February 2027)
- The Advanced Research on Cancer Immunology (Deadline: 30 April 2027)
- Therapeutic Cancer Vaccines: Advances, Challenges, and Future Directions (Deadline: 31 May 2027)
- Anti-Cancer Immunity: Mechanisms, Biomarkers, and Vaccine-Based Therapeutic Strategies (Deadline: 31 July 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
